ABA Chemicals to Invest in CDMO/CRO Services Firm

MT Newswires Live

02-10

ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.

The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.

While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2510335178"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510335178\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2510335178?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-10 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510335178","market":"sg","top_or_hot":-1,"title":"ABA Chemicals to Invest in CDMO/CRO Services Firm","media":"MT Newswires Live","content":"<html><body><p> ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.</p><p>The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.</p><p>While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ABA Chemicals to Invest in CDMO/CRO Services Firm</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nABA Chemicals to Invest in CDMO/CRO Services Firm\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-10 16:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.</p><p>The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.</p><p>While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0229","symbol_name":"化学制品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2510335178","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510335178","pubTimestamp":1739176709,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ABA Chemicals  plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300261":"雅本化学","BK0229":"化学制品","CDMO":"Avid Bioservices, Inc.","BK4139":"生物科技","BK0174":"增持","BK0028":"国家队"},"translate_title":"ABA Chemicals将投资CDMO/CRO服务公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300261":0.9,"CDMO":1},"content_text":"ABA Chemicals (SHE:300261) plans to invest in Gansu Haotian Technology by acquiring existing shares and possibly subscribing to newly registered capital, according to a Monday filing with the Shenzhen Stock Exchange.The move aims to enhance ABA Chemicals's pharmaceutical business by leveraging Haotian's CDMO and CRO expertise.While discussions are ongoing, no formal agreement has been signed, and the investment structure is yet to be finalized. Further disclosures will be made as the deal progresses.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}